Uniwersytecki Szpital Kliniczny W Olsztynie
- Address
- Aleja Warszawska 30, 10-082 Olsztyn, Poland
Uniwersytecki Szpital Kliniczny W Olsztynie - Cardiovascular Research Center
Uniwersytecki Szpital Kliniczny W Olsztynie is a leading academic medical center specializing in cardiovascular disease research and treatment optimization. The center focuses on complex cardiovascular conditions requiring advanced diagnostic approaches and innovative therapeutic strategies, with particular emphasis on difficult-to-treat hypertension and acute pulmonary embolism.
- Management of resistant and difficult-to-treat hypertension using combination therapy and ABPM monitoring
- Optimized thrombolytic therapy protocols for intermediate-high-risk acute pulmonary embolism
- Comparative effectiveness research of antihypertensive medications including spironolactone, eplerenone, and torasemide
The center's research portfolio demonstrates expertise in both chronic cardiovascular disease management and acute life-threatening conditions. Their trials utilize sophisticated blood pressure monitoring techniques including 24-hour ambulatory blood pressure monitoring (ABPM) to evaluate treatment efficacy. The center is committed to advancing evidence-based treatment protocols that balance therapeutic effectiveness with patient safety, particularly in high-risk populations requiring careful titration of pharmacological interventions.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 3 by active trials.
- 1Zenas Biopharma (USA) LLC2active
lock +2 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Zenas Biopharma (USA) LLC2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Uniwersytecki Szpital Kliniczny W Olsztynie
lock Showing 1 of 4 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Eplerenone, Spironolactone, and Torasemide in the Management of Resistant Hypertension in Patients with Uncontrolled Blood Pressure | Agencja Badań Medycznych, Narodowy Instytut Kardiologii Stefana Kardynala Wyszynskiego Panstwowy Instytut Badawczy | Phase I | Recruiting | Oct 2023 | — |
IMP list
lock Showing 1 of 10 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Alteplase | 1 | Unknown | 2021-08-04 | 2021-08-04 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.